FDA Grants Survodutide Breakthrough Therapy Designation

[geoguy78]

Thought some might find this interesting. Lots of research is showing benefits for the liver with the new GLP-1/glucagon receptor agonists in the pipeline,

Zealand Pharma announces that Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two Phase III trials in MASH for survodutide

 

[Dee X]

LIVERAGE-Cirrhosis is huge.

 

[Dee X]

If only a glp1 could also repair all the life and relationship destruction….

Well now you can, using DeeX's revolutionary patent-pending Green Light Therapy!